Discovery of Genes Related to Cuproptosis and Mitophagy to Improve Myocardial Infarction Diagnosis and Treatment

Curr Gene Ther. 2026 Feb 26. doi: 10.2174/0115665232440699251209120654. Online ahead of print.ABSTRACTINTRODUCTION: Emerging evidence links cuproptosis and mitophagy to the progression of myocardial infarction (MI). This study explored cuproptosis- and mitophagy-related gene modules in MI, aiming to

F Fenlong Xue

Prognostic value of the FBG/HDL-C ratio for 28-day all-cause mortality in critically ill patients: a retrospective cohort study with external validation

Eur J Med Res. 2026 Feb 28. doi: 10.1186/s40001-026-04141-1. Online ahead of print.ABSTRACTBACKGROUND: Metabolic dysregulation in critical illness may involve early changes in early morning fasting blood glucose (FBG) and high-density lipoprotein cholesterol (HDL-C), but the prognostic value of comb

X Xiao-Jun Xiang

Emerging cardiovascular risks of micro- and nanoplastics: toxic effects and mechanistic pathways

Part Fibre Toxicol. 2026 Feb 28. doi: 10.1186/s12989-026-00669-6. Online ahead of print.ABSTRACTMicro- and nanoplastics (MNPs), due to their widespread distribution and chemical stability, have emerged as novel environmental contaminants threatening cardiovascular health. Evidence links MNPs to cond

G Gang Liu

Multi-ancestry genome-wide association study and meta-analysis of lung function decline

No abstractRespir Res. 2026 Feb 28. doi: 10.1186/s12931-026-03565-x. Online ahead of print.NO ABSTRACTPMID:41764487 | DOI:10.1186/s12931-026-03565-x

B Bonnie K Patchen

Multi-trajectory modeling of metabolic syndrome indicators and cardiovascular disease risk: a study based on health examination big data

No abstractBMC Endocr Disord. 2026 Feb 28. doi: 10.1186/s12902-026-02211-3. Online ahead of print.NO ABSTRACTPMID:41764469 | DOI:10.1186/s12902-026-02211-3

M Mingwang Fu

Association between social activities and cardiovascular diseases: evidence from the CHARLS database

No abstractBMC Public Health. 2026 Feb 28. doi: 10.1186/s12889-026-26872-w. Online ahead of print.NO ABSTRACTPMID:41764464 | DOI:10.1186/s12889-026-26872-w

H Hongmiao Tao

Where evidence becomes action

No abstractEur Heart J Acute Cardiovasc Care. 2026 Mar 1:zuag005. doi: 10.1093/ehjacc/zuag005. Online ahead of print.NO ABSTRACTPMID:41764359 | DOI:10.1093/ehjacc/zuag005

P Pascal Vranckx

Ultrasound-guided left heart injection: a safer and more efficient strategy for mouse thoracic aortic gene delivery

Gene Ther. 2026 Feb 28. doi: 10.1038/s41434-026-00603-7. Online ahead of print.ABSTRACTThoracic aortic disease poses a significant threat due to its high mortality rates and genetic. underpinnings. While gene therapy holds promise for cures, the challenge lies in achieving. effective and safe gene d

Y Yanmiao Yang

Whole exome sequencing and 12-SNP LDL polygenic score in South Indian patients with familial hypercholesterolemia

Sci Rep. 2026 Feb 28. doi: 10.1038/s41598-026-40367-z. Online ahead of print.ABSTRACTHeterozygous familial hypercholesterolemia (FH), a monogenic cause for premature coronary artery disease (CAD) is often underdiagnosed. In individuals who meet the FH diagnostic criteria and lack pathogenic variants

N Nithya Abraham

Endoluminal Catheter Pulsed Field Ablation for the Treatment of Atherosclerotic Vascular Disease

Ann Biomed Eng. 2026 Feb 28. doi: 10.1007/s10439-026-04044-6. Online ahead of print.ABSTRACTPURPOSE: Atherosclerotic vascular disease remains a leading cause of morbidity and mortality worldwide. Current treatments such as angioplasty, stenting, and atherectomy are invasive and limited by restenosis

Z Zaid S Salameh

Comparative Mid-Term Outcomes of Endovascular Strategies for Femoropopliteal Lesions Extending to the Distal Popliteal Artery

Cardiovasc Intervent Radiol. 2026 Mar 1. doi: 10.1007/s00270-026-04393-8. Online ahead of print.ABSTRACTPURPOSE: To compare endovascular strategies for femoropopliteal lesions extending to the distal popliteal artery (PA).MATERIALS AND METHODS: We retrospectively analyzed 275 femoropopliteal lesions

S Sho Nakao

Lipidated Interleukin-22 Reduces Body Weight And Spares Lean Mass In Mice By A Novel Gut Acting Mechanism Additive To GLP-1 Agonism

Mol Ther. 2026 Feb 27:S1525-0016(26)00127-9. doi: 10.1016/j.ymthe.2026.02.041. Online ahead of print.ABSTRACTThe prevalence of metabolic diseases, including obesity and type 2 diabetes, continues to rise. Although GLP-1 receptor agonists (GLP-1RAs) now provide the first effective treatment options f

D Daniela Hass

Cytokine specificity in macrophages: JAK-STAT and beyond

Trends Immunol. 2026 Feb 27:S1471-4906(26)00002-5. doi: 10.1016/j.it.2026.01.002. Online ahead of print.ABSTRACTMacrophages are key in maintaining tissue homeostasis and controlling inflammation. To rapidly adapt their phenotype, they rely on JAK-STAT signaling pathways to convert extracellular cyto

J Josje M A Huisman

Global Practices for Reprocessing Endocavity Ultrasound Transducers: Insights From a WFUMB Survey

Ultrasound Med Biol. 2026 Feb 27:S0301-5629(26)00030-X. doi: 10.1016/j.ultrasmedbio.2026.01.013. Online ahead of print.ABSTRACTOBJECTIVE: To determine the international availability of practice guidelines, training in and method used for the reprocessing of endocavity (EC) ultrasound transducers pos

S Susan Campbell Westerway

Cancer treatment-related ischemic arterial events: Focus on peripheral arterial disease and cerebrovascular events

Vasc Dis (Paris). 2026 Feb 27:S3050-6581(26)00178-0. doi: 10.1016/j.vasdi.2026.02.006. Online ahead of print.ABSTRACTCancer therapies, including VEGF inhibitors, BCR-ABL tyrosine kinase inhibitors (TKIs), immune checkpoint inhibitors (ICIs), multiple myeloma and hormonal therapies, are associated wi

G Gilles Pernod

Lipid-modifying efficacy and safety of obicetrapib in high-risk cardiovascular patients: A systematic review and meta-analysis

Vasc Dis (Paris). 2026 Feb 27:S3050-6581(26)00176-7. doi: 10.1016/j.vasdi.2026.02.004. Online ahead of print.ABSTRACTINTRODUCTION: Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality, particularly among high-risk patients. Despite the availability of mul

A Abdul Mueez Alam Kayani

Physician knowledge and practices regarding cardiovascular risk assessment and LDL-cholesterol targets determination: A monocentric cross-sectional survey

Vasc Dis (Paris). 2026 Feb 27:S3050-6581(26)00179-2. doi: 10.1016/j.vasdi.2026.02.007. Online ahead of print.ABSTRACTBACKGROUND: Cardiovascular diseases (CVD) remain the leading global cause of mortality. Approximately 50% of the CVD burden is attributable to five modifiable risk factors, including

G Giovanni Orecchio

Contemporary approaches to perioperative anticoagulant management in surgical patients: a literature review

Curr Med Res Opin. 2026 Feb 28:1-11. doi: 10.1080/03007995.2026.2627734. Online ahead of print.ABSTRACTPerioperative anticoagulation management requires balancing thromboembolic prevention with bleeding risk. With the growing use of oral anticoagulants, this review synthesizes current evidence and g

R Raden Mohammad Budiarto

Clopidogrel versus aspirin for coronary artery disease - Authors' reply

No abstractLancet. 2026 Feb 28;407(10531):853-854. doi: 10.1016/S0140-6736(26)00186-8.NO ABSTRACTPMID:41763741 | DOI:10.1016/S0140-6736(26)00186-8

M Marco Valgimigli

Clopidogrel versus aspirin for coronary artery disease

No abstractLancet. 2026 Feb 28;407(10531):852-853. doi: 10.1016/S0140-6736(25)02644-3.NO ABSTRACTPMID:41763739 | DOI:10.1016/S0140-6736(25)02644-3

C Cinzia Dello Russo

Cracking Coronary Calcium with Intravascular Lithotripsy A Review

Am J Cardiol. 2026 Feb 26:S0002-9149(26)00083-4. doi: 10.1016/j.amjcard.2026.02.032. Online ahead of print.ABSTRACTCalcified coronary lesions (CCL) remain a major challenge in percutaneous coronary intervention, often limiting stent expansion and worsening long-term outcomes. Conventional calcium mo

S Sachin Kumar

Association of Coronary Microvascular Dysfunction with Lipoprotein (a) levels in Patients with Non-Obstructive Coronary Artery Disease

Am J Cardiol. 2026 Feb 26:S0002-9149(26)00092-5. doi: 10.1016/j.amjcard.2026.02.038. Online ahead of print.ABSTRACTCoronary microvascular dysfunction (CMD) constitutes an increasingly acknowledged aspect of coronary artery disease. Even though traditional cardiovascular risk factors have been implic

E Eleni Adamopoulou

Mechanisms of Symptomatic Lower Extremity Artery Disease in Femoropopliteal Arteries Assessed by Optical Frequency Domain Imaging

Am J Cardiol. 2026 Feb 26:S0002-9149(26)00099-8. doi: 10.1016/j.amjcard.2026.02.046. Online ahead of print.ABSTRACTDifferent vascular beds show different tissue characteristics. The mechanism of progression at the culprit site in femoropopliteal arteries remains unclear. This study aims to assess th

H Hiroyuki Jinnouchi

Antiarrhythmic drugs to prevent sudden cardiac death: Is there a way forward?

Pharmacol Ther. 2026 Feb 26:109012. doi: 10.1016/j.pharmthera.2026.109012. Online ahead of print.ABSTRACTSudden cardiac death (SCD) is responsible for approximately 15-20% of deaths worldwide. The majority of SCD cases can be attributed to lethal ventricular arrhythmias arising due to coronary heart

I Iris Zieler